SNHG۶ ۲۰۳ RNA May be Involved in the Cell Cycle Progression in HER۲-Negative Breast Cancer Cells
Publish place: IRANIAN JOURNAL of PATHOLOGY، Vol: 17، Issue: 3
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 192
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-17-3_001
تاریخ نمایه سازی: 8 شهریور 1401
Abstract:
Background & Objective: Long noncoding RNAs (lncRNAs) as challenging molecules are more known compared to those in the last decade. These transcripts have been validated for carcinogenesis in many types of tissue. Functions of lncRNAs in cancer induction include cell cycle, epithelial to mesenchymal transition progression, apoptosis inhibition, cell migration, and invasion stimulation . LncRNA small nucleolar host (SNHG۶) have been proven as an oncogenic transcript in many types of cancer.Methods: RNA extraction was performed for ۴۷ breast specimens in patients with cancer and cDNAs were synthesized. Relative expression of target variants was determined by qPCR and calculated based on the ΔΔCt method. SNHG۶ ۲۰۳ was cloned into pcDNA ۳.۱+ vector for overexpression in MCF۷ (HER۲-) and SK-BR۳ (HER۲+) cells. The cell cycle progression of transfected cells was assessed by flow cytometry. Cell migration ability of transfected cells was evaluated by the scratch method and Image J software. Finally, cell viability was assessed by the MTT method.Results: Among four splice variants of SNHG۶ (۲۰۲, ۲۰۳, ۲۰۴, and ۲۰۷), SNHG۶ ۲۰۳ was proved as an overexpressed splice variant in breast cancer tumors. This transcript was expressed in HER۲-negative breast tumors more frequently than in the positive ones. Overexpression of this variant in target cells resulted in cell cycle progression of MCF۷ as HER۲-negative cells. Moreover, the overexpression of SNHG۶ ۲۰۳ led to a lower migration ability of MCF۷ cells and a non-significant reduction of their viability as HER۲-negative breast cancer cells.
Keywords:
Authors
Amin Jafari Oliayi
Pathology and Stem Cell Research Center, Department of Pathology, Afzalipour Medical School, Kerman University of Medical Sciences, Kerman, Iran
Shahriar Dabiri
Pathology and Stem Cell Research Center, Department of Pathology, Afzalipour Medical School, Kerman University of Medical Sciences, Kerman, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :